FibroGen, Inc. (FGEN)

Operating Cash Flow Growth

-62.34%

TTM · Period ending:

FGEN logo

FGEN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-62.34%
FGEN TTM Cash from Operations YoY % (-13.52% → -62.34%)
High-resolution chart · PNG

FGEN operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

FibroGen, Inc. Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-62.3352%
71.8655%
96.5406%
86.5622%
88.3965%
72.1353%
56.1937%
63.9607%
36.183%
-14.085%
-115.8669%
-135.3505%
-505.9049%
-422.8064%
-77.465%
-330.087%
34.7785%
-147.5776%
-200.772%
-178.8031%
-553.9499%
159.8142%
203.6808%
185.6416%
214.6663%
-640.3852%
-3.3634%
14.6079%
82.2189%
69.5813%
-14.4799%
28.6234%
-28.7806%
-2,476.4175%
-1,035.7485%
-514.4469%
-34.3885%
-143.5309%
138.2747%
-350.0495%
-1,339.9702%
249.4947%
-182.8545%
-112.8894%
-96.8593%
-114.3295%
-13.5196%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.